Omnipod 5 pump study for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study follows people with type 1 diabetes who are using the Omnipod 5 insulin pump. The goal is to understand how well the system works in everyday life by collecting data from your pump, continuous glucose monitor, and occasional home blood tests over one year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes.
- You are already using the Omnipod 5 pump or will start using it within the next two weeks.
- You are willing to use one of these insulins: Humalog, Novolog, or Admelog.
- You are able to read and speak English (or Spanish) and live full-time in the United States.
- You are not pregnant and will not plan pregnancy for the next 12 months.
- You can use a home kit to collect a small blood sample (A1C) a few times a year and answer online questionnaires every two weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study is testing how well the Omnipod 5 insulin pump works in everyday life for people with type 1 diabetes. It's for people who are just starting to use this pump, so doctors can see how it helps manage blood sugar in real-world settings.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests whether starting automated insulin delivery (a system that adjusts insulin automatically) early after diagnosis helps children and teens with type 1 diabetes manage their blood sugar better. It also looks at long-term health and costs.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a new insulin pump system (Tandem Mobi) with a continuous glucose monitor for young athletes with type 1 diabetes. It looks at how well the system works and how it feels to use during sports.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.